SweetValueLab
Write for us

ConocoPhillips vs ExxonMobil COP vs XOM

ConocoPhillips and ExxonMobil on one sheet: valuation multiples, growth, margins, debt, dividends and returns, each section labelled with the period it covers, from the companies' filings. Add or remove a stock above the sheet; the link holds the set.

Compare other stocks
COPXOM
Often compared:+ CVX

What differs most

generated from the numbers below
  • Market value: ExxonMobil $735.95B, ConocoPhillips $176.01B.
  • Debt / equity: ConocoPhillips 0.4×, ExxonMobil 0.2×.
  • Net margin: ConocoPhillips 16.5%, ExxonMobil 10.1%.
  • Price / sales: ConocoPhillips 3.1×, ExxonMobil 2.1×.

Price return

2025-10-16 → 2026-10-16
COP+68.6%
XOM+61.8%
-20%0%20%40%60%80%2025-10-162026-04-172026-10-16
Prices at the close on 2026-10-16

Profile

latest
Sector
Energy
Energy
Industry
Oil & Gas Exploration & Production
Oil & Gas Integrated
Market value
$176.01B
$735.95B
Enterprise value
$192.72B
$767.73B
Employees
9,600
57,900
Revenue per employee (TTM)
$5.9M
$6.2M

Our models

nightlythe valuation on each stock's page
Price vs model
24% undervalued vs model
13% overvalued vs model
Model range
$106–416
$94.61–386
Models in the headline
1
1
FCF growth priced in, at a 10% return
−0.6%
18.5%
Every model, its assumptions and its range: COP valuation · XOM valuation. The growth priced in, at any return: COP reverse DCF · XOM reverse DCF.

Trading

close 2026-10-16
Last close
$146.51
$178.98
52-week high
$146.51
$178.98
52-week low
$85.66
$112.24
Price vs 52-week high
0.0%
0.0%
Price vs 52-week low
+71.0%
+59.5%
Average daily volume / shares
0.6%
0.3%
Beta
0.13
0.17

Returns

to 2026-10-16
1 month
+10.5%
+9.6%
3 months
+29.8%
+22.6%
6 months
+20.5%
+17.8%
Year to date
+56.5%
+48.7%
1 year
+68.6%
+61.8%
1 year, dividends added
+72.4%
+65.5%
2 years
+39.3%
+48.3%

Valuation

price × TTM to Jun 2026
P/E (TTM)
19.4×
21.0×
P/E on consensus EPS (next FY)
13.2×
14.5×
Price / sales
3.1×
2.1×
EV / sales
3.4×
2.1×
EV / EBITDA
—
—
Price / book
2.7×
2.8×
Price / free cash flow (FY)
—
31.2×
Free-cash-flow yield (FY)
—
3.2%

Growth

TTM and FY2025
Revenue growth (TTM)
—
—
Revenue growth, consensus next FY
+40.5%
+29.3%
Revenue, 3-year CAGR
−5.3%
−6.7%
Revenue, 5-year CAGR
22.5%
12.6%
EPS growth (TTM)
—
—
EPS growth, consensus next FY
+74.3%
+84.6%
EPS, 3-year CAGR
−24.2%
−20.4%
Free cash flow, 3-year CAGR
−2.6%
−26.1%
Diluted shares, 3-year change
−1.9%
+2.4%

Profitability

TTM to Jun 2026
Gross margin (FY)†
25.1%
21.7%
Operating margin
—
—
EBITDA margin
—
—
Net margin
16.5%
10.1%
Free-cash-flow margin (FY)
—
7.3%
Return on equity
14.2%
14.0%
Return on assets
7.5%
7.8%
Asset turnover
0.45
0.77
† Gross margin (FY): As filed. Companies draw the cost-of-revenue line in different places, so gross margins of two companies in one industry can differ for that reason alone; operating margin does not depend on where the line is drawn.

Balance sheet

MRQ Jun 2026
Cash
$6.57B
$10.59B
Total debt
$23.29B
$42.37B
Net debt
$16.72B
$31.78B
Debt / equity
0.4×
0.2×
Net debt / EBITDA (TTM)
—
—
Interest coverage (FY)
9.2×
56.3×
Current ratio (FY)
1.30
1.15

Dividends

trailing 12 months
Dividend yield
2.3%
2.3%
Dividends per share
$3.36
$4.12
Payout ratio (of TTM EPS)
44.4%
48.2%
Dividend per share, 5-year CAGR
21.1%
3.4%
Frequency
Quarterly
Quarterly

Ownership and activity

last 90 days · latest 13F
Tracked superinvestors holding (13F)
8
11
Insider open-market buys (Form 4)
$0
$0
Insider sales (Form 4)
$3.3M
$0
Analyst upgrades
0
1
Analyst downgrades
0
2

Statements

income TTM to Jun 2026 · cash flow FY2025
Revenue
$56.31B
$358.42B
EBITDA
—
—
Operating income
—
—
Net income
$9.28B
$36.29B
EPS (diluted)
$7.57
$8.54
Operating cash flow
$19.80B
$51.97B
Capital expenditure
—
−$28.36B
Free cash flow
—
$23.61B
Dividends paid
$4.00B
$17.23B

Keep comparing

the matchups people search for

ConocoPhillips against

ExxonMobil against

Statements from the companies' SEC filings; prices, dividends and consensus estimates from Financial Modeling Prep; insider trades from Form 4 and holdings from 13F. Refreshed nightly. A comparison of filed numbers, not a recommendation to buy, sell or hold any security.